For the first time an artificial intelligence has independently created a cure for people
The first drug, created by the artificial intelligence, is entering the stage of clinical trials in humans. According to scientists it is a breakthrough in medicine and pharmaceuticals.
The new drug was designed by the artificial intelligence biotechnology company, located in Oxford. The drug is intended to treat obsessive-compulsive disorder.
A molecule, known as DSP-1181, was created using algorithms that sifted potential compounds by comparing them with a huge database of parameters.
A Japanese pharmaceutical company has entered into a partnership agreement to access Exscientia platform for automated data analysis of patient to search for new molecules. The artificial intelligence has developed the drug for 12 months. Researchers usually take at least 4.5 years to implement a new drug in a clinical trial in humans.